Skip Navigation

Nicotine & Tobacco Research 2004 6(4):631-639; doi:10.1080/14622200410001727885
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Busch, S. H.
Right arrow Articles by Sindelar, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Busch, S. H.
Right arrow Articles by Sindelar, J. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Society for Research on Nicotine and Tobacco

Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey

Susan H. Busch, Ph.D., Tracy A. Falba, Ph.D., Noelia Duchovny, Ph.D., Mireia Jofre-Bonet, Ph.D., Stephanie S. O'Malley, Ph.D. and Jody L. Sindelar, Ph.D.

Department of Epidemiology and Public Health, Yale University School of Medicine, and Center for Nicotine and Tobacco Use Research at Yale New Haven, CT
Congressional Budget Office Washington DC
Center of Research in Health Economics (CRES) Barcelona, Spain, and Health Economists' Study Group United Kingdom
Center for Nicotine and Tobacco Use Research at Yale, and Department of Psychiatry, Yale University School of Medicine New Haven, CT

Correspondence: Susan H. Busch, Ph.D., Yale School of Medicine, LEPH, 60 College Street; Suite 300B, New Haven, CT 06520, USA. Tel.: +1 (203)-785-2927; Fax: +1 (203)-785-6287; E-mail: susan.busch{at}yale.edu


  Abstract

The present study demonstrated the use of willingness to pay to value hypothetical new smoking cessation products. Data came from a baseline survey of participants in a clinical trial of medications for smoking cessation (N=356) conducted in New Haven, Connecticut. We analyzed individual willingness to pay for a hypothetical tobacco cessation treatment that is (a) more effective than those currently available and then (b) more effective and attenuates the weight gain often associated with smoking cessation. A majority of the respondents (n=280; 84%) were willing to pay for the more effective treatment, and, of those, 175 (63%) were willing to pay more if the increased effectiveness was accompanied by attenuation of the weight gain associated with smoking cessation. The present study suggests the validity of using willingness-to-pay surveys in assessing the value of new smoking cessation products and products with multifaceted improvements. From these data, we calculated estimates of the value of a quit. For the population studied, this survey suggests a substantial market for more effective smoking cessation treatments.

Received: June 30, 2003; Accepted: March 3, 2004
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.